# Lidocaine Infusion Versus Magnesium Infusion in Decreasing Fentanyl Requirements in Endoscopic Sinus Surgeries

> **NCT06966102** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 156 (estimated)

## Conditions studied

- Enhanced Recovery
- Functional Endoscopic Sinus Surgery
- Lidocaine
- Magnesium Sulphate
- Perioperative Pain

## Interventions

- **DRUG:** Lidocaine group
- **DRUG:** Magnesium group
- **DRUG:** Control group

## Key facts

- **NCT ID:** NCT06966102
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-10
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-07-30
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966102, "Lidocaine Infusion Versus Magnesium Infusion in Decreasing Fentanyl Requirements in Endoscopic Sinus Surgeries". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06966102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*